Adalimumab-related Spondylodiscitis: A Side Effect to be Taken into Consideration
Open Access
- 15 May 2026
- journal article
- case report
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 117 (9) , 104671
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología sobre el manejo del paciente de edad avanzada con psoriasis en placas moderada-graveActas Dermo-Sifiliograficas, 2023
- Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A ReviewAmerican Journal of Clinical Dermatology, 2021
- Adalimumab-associated spondylodiscitis: A new or underestimated side effect?Dermatologic Therapy, 2020
- Risk of Serious Infection With Biologic and Systemic Treatment of PsoriasisJAMA Dermatology, 2015
- Evidence-based adverse effects of biologic agents in the treatment of moderate-to-severe psoriasis: Providing clarity to an opaque topicJournal of Dermatological Treatment, 2015
- Infectious spondylodiscitisJournal of Infection, 2008